W K Cavenee Selected Research

W K Cavenee Research Topics

Disease

13	Neoplasms (Cancer) 07/2015 - 02/2000
9	Glioma (Gliomas) 05/2014 - 01/2000
8	Glioblastoma (Glioblastoma Multiforme) 07/2015 - 07/2000
2	Brain Neoplasms (Brain Tumor) 05/2014 - 12/2001
2	Prostatic Neoplasms (Prostate Cancer) 01/2001 - 05/2000
1	Carcinogenesis 05/2014
1	Cerebral Hemorrhage 12/2001
1	Rupture 12/2001
1	Necrosis 07/2001
1	Alveolar Rhabdomyosarcoma 02/2001
1	Oligodendroglioma 01/2000
1	Astrocytoma (Pilocytic Astrocytoma) 01/2000

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 07/2015 - 01/2001
5	epidermal growth factor receptor VIIIIBA 07/2015 - 07/2001
4	DNA (Deoxyribonucleic Acid)IBA 09/2012 - 02/2000
3	Phosphotransferases (Kinase)IBA 05/2014 - 07/2001
3	Cisplatin (Platino)FDA LinkGeneric 09/2001 - 02/2000
2	Epidermal Growth Factor (EGF)IBA 07/2015 - 07/2001
2	Proteins (Proteins, Gene)FDA Link 05/2014 - 02/2001
2	Monoclonal AntibodiesIBA 07/2001 - 07/2001
2	monoclonal antibody 806IBA 07/2001 - 07/2001
1	src-Family KinasesIBA 07/2015
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 05/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 05/2014
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 05/2014
1	protein kinase modulatorIBA 05/2014
1	Serine (L-Serine)FDA Link 05/2014
1	KT 5720IBA 05/2014
1	JNK Mitogen-Activated Protein KinasesIBA 09/2012
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2012
1	InterleukinsIBA 09/2012
1	Interleukin-8 (Interleukin 8)IBA 09/2012
1	CytokinesIBA 09/2012
1	Protein Tyrosine PhosphatasesIBA 12/2001
1	Mitogen-Activated Protein KinasesIBA 12/2001
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2001
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2001
1	Protein Isoforms (Isoforms)IBA 12/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2001
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 09/2001
1	RTKI cpdIBA 09/2001
1	TyrphostinsIBA 09/2001
1	deoxyuridine triphosphateIBA 09/2001
1	Tyrosine Kinase InhibitorsIBA 09/2001
1	Amino Acids FDA Link 07/2001
1	DNA-Binding Proteins (DNA Binding Protein)IBA 06/2001
1	SilverIBA 05/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2001
1	AnnexinsIBA 01/2001
1	Peptides (Polypeptides)IBA 07/2000
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2000
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2000
1	Somatomedin Receptors (Somatomedin Receptor)IBA 05/2000
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2000
1	Etoposide (VP 16)FDA LinkGeneric 02/2000
1	LigandsIBA 02/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2000
1	Death Domain ReceptorsIBA 02/2000
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 02/2000
1	Messenger RNA (mRNA)IBA 01/2000
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2000
1	CarcinogensIBA 01/2000

Therapy/Procedure

3	Therapeutics 07/2015 - 07/2000
1	Drug Therapy (Chemotherapy) 06/2001